PETROS PHARMACEUTICALS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6399 USD | 0.00% |
|
-4.51% | -54.62% |
Chart calendar Petros Pharmaceuticals
6a1b8d1d4cad66c8a851.s_UGlp_5RVfWKvRD6cyGuaH_lt0IlhuGUiSM7_XErqw.4aF17O2BdjSCTocJiJzfz8-z3JZtzn3MKEnVt6T0m5XkmD7v7bEDNJRGhw~28e58541198e99aafac75cbc4e64f54b
Upcoming events on Petros Pharmaceuticals
No events available
Past events on Petros Pharmaceuticals
| 15/08/2022 13:00 | Interim 2022 Earnings Release |
| 16/05/2022 22:00 | Q1 2022 Earnings Release |
| 04/05/2022 18:00 | Planet MicroCap Showcase |
| 01/04/2022 12:00 | FY 2021 Earnings Release |
| 09/03/2022 19:00 | Investor Summit Group Virtual Investor Summit |
| 07/03/2022 | Investor Summit Group Virtual Investor Summit |
| 16/01/2022 | Biotech Showcase |
| 10/01/2022 12:00 | H.C. Wainwright BioConnect Conference |
| 09/01/2022 | Biotech Showcase |
| 08/12/2021 18:35 | Benzinga Global SmallCAP Conference |
| 17/11/2021 18:15 | FY Investor Summit |
| 15/11/2021 21:30 | Q3 2021 Earnings Release |
| 30/09/2021 19:40 | Benzinga Healthcare Small Cap Conference |
| 13/09/2021 12:00 | H.C. Wainwright Global Investment Conference |
| 18/08/2021 21:00 | SNN Network Summer Investor Conference |
| 17/08/2021 17:30 | Q3 Investor Summit |
| 17/08/2021 14:25 | Interim 2021 Earnings Release |
| 14/07/2021 20:30 | Issuer Direct Access to Giving Virtual Investor Conference |
| 10/06/2021 21:00 | LD Micro Invitational Investor Conference |
| 18/05/2021 14:30 | Investor Summit |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 5,82 7,70 -24.41% | 5,67 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -13,6 -10,8 -25.92% | -12,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -8,16 -10,9 24.9% | -12,8 |
|
Net income Million USD | Released Forecast Spread | -20,0 | -8,16 -10,9 24.9% | -12,8 |
|
EPS USD | Released Forecast Spread | -9,68 | -6,35 -5,15 -23.3% | -6,01 |
| Announcement Date | 31/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,55 | 1,45 | 1,43 | 1,40 | 1,38 |
|
EBIT Million USD | Released Forecast Spread | -2,20 | -2,90 | -2,99 | -3,09 | -3,19 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,35 | -3,05 | -3,15 | -3,24 | -3,34 |
|
Net income Million USD | Released Forecast Spread | -2,35 | -3,05 | -3,15 | -3,24 | -3,34 |
|
EPS USD | Released Forecast Spread | -1,11 | -1,44 | -1,48 | -1,52 | -1,57 |
| Announcement Date | - | - | - | - | - |
Past sector events for Petros Pharmaceuticals
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PTPI Stock
- Calendar Petros Pharmaceuticals
